TY - JOUR
KW - Adult
KW - Analgesics, Opioid/agonists/therapeutic use
KW - Baltimore
KW - Crime/statistics & numerical data
KW - Female
KW - Heroin Dependence/drug therapy/rehabilitation
KW - Humans
KW - Longitudinal Studies
KW - Male
KW - Methadone/therapeutic use
KW - Methadyl Acetate/therapeutic use
KW - Middle Aged
KW - Opioid-Related Disorders/drug therapy/rehabilitation
KW - Patient Compliance
KW - prisoners
KW - Proportional Hazards Models
KW - Treatment Outcome
KW - Young Adult
AU - J. Gryczynski
AU - T. W. Kinlock
AU - S. M. Kelly
AU - K. E. O'Grady
AU - M. S. Gordon
AU - R. P. Schwartz
A1 - 
AB - This study examined outcomes and their predictors among 181 probationers enrolling in opioid agonist maintenance with methadone or levo-alpha-acetylmethadol (LAAM). Participants were interviewed at treatment entry and 2-, 6-, and 12-month follow-ups. Treatment retention and frequency of heroin use, cocaine use, and income-generating criminal activity were examined using survival and longitudinal analyses. Participants reported marked reductions in drug use and crime relative to treatment entry. A number of patient characteristics associated with various outcomes were identified. The findings support engaging probationers in treatment and highlight patient factors that might influence outcomes.
BT - Substance abuse
C5 - Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1080/08897077.2011.616816
IS - 1
JF - Substance abuse
N2 - This study examined outcomes and their predictors among 181 probationers enrolling in opioid agonist maintenance with methadone or levo-alpha-acetylmethadol (LAAM). Participants were interviewed at treatment entry and 2-, 6-, and 12-month follow-ups. Treatment retention and frequency of heroin use, cocaine use, and income-generating criminal activity were examined using survival and longitudinal analyses. Participants reported marked reductions in drug use and crime relative to treatment entry. A number of patient characteristics associated with various outcomes were identified. The findings support engaging probationers in treatment and highlight patient factors that might influence outcomes.
PP - United States
PY - 2012
SN - 1547-0164; 0889-7077
SP - 30
EP - 39
EP - 
T1 - Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime
T2 - Substance abuse
TI - Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime
U1 - Opioids & Substance Use
U2 - 22263711
U3 - 10.1080/08897077.2011.616816
VL - 33
VO - 1547-0164; 0889-7077
Y1 - 2012
ER -